|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/28/17 Bank of New York Mellon Corp 10-K 12/31/16 172:44M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 280K
3: EX-13.1 All Portions of 2016 Annual Report to Shareholders HTML 3.83M
5: EX-21.1 Primary Subsidiaries of the Company HTML 60K
6: EX-23.1 Consent of Kpmg LLP HTML 53K
7: EX-24.1 Power of Attorney HTML 58K
2: EX-12.1 Computation of Ratio of Earnings to Combined Fixed HTML 72K
Charges and Preferred Stock D
4: EX-18.1 Preferability Letter From Kpmg LLP for Change in HTML 50K
Accounting Principle
8: EX-31.1 Section 302 CEO Certification HTML 55K
9: EX-31.2 Section 302 CFO Certification HTML 55K
10: EX-32.1 Section 906 CEO Certification HTML 49K
11: EX-32.2 Section 906 CFO Certification HTML 49K
18: R1 Document and Entity Information HTML 77K
19: R2 Consolidated Income Statement HTML 190K
20: R3 Consolidated Income Statement (Unaudited) HTML 51K
(Parenthetical)
21: R4 Consolidated Comprehensive Income Statement HTML 103K
22: R5 Consolidated Comprehensive Income Statement HTML 51K
(Parenthetical)
23: R6 Consolidated Balance Sheet HTML 186K
24: R7 Consolidated Balance Sheet (Parenthetical) HTML 76K
25: R8 Consolidated Statement of Cash Flows HTML 201K
26: R9 Consolidated Statement of Changes in Equity HTML 129K
27: R10 Consolidated Statement of Changes in Equity HTML 54K
(Parenthetical)
28: R11 Summary of significant accounting and reporting HTML 146K
policies
29: R12 Acquisitions and dispositions HTML 59K
30: R13 Securities HTML 625K
31: R14 Loans and asset quality HTML 520K
32: R15 Goodwill and intangible assets HTML 177K
33: R16 Other assets HTML 99K
34: R17 Deposits HTML 53K
35: R18 Net interest revenue HTML 90K
36: R19 Noninterest Expense HTML 82K
37: R20 Income taxes HTML 140K
38: R21 Long-Term Debt HTML 109K
39: R22 Securitizations and variable interest entities HTML 112K
40: R23 Shareholders' equity HTML 108K
41: R24 Other comprehensive income (Loss) HTML 188K
42: R25 Stock-based compensation HTML 119K
43: R26 Employee benefit plans HTML 583K
44: R27 Company Financial Information HTML 178K
45: R28 Fair value measurement HTML 796K
46: R29 Fair value option HTML 82K
47: R30 Commitments and contingent liabilities HTML 133K
48: R31 Derivative instruments HTML 475K
49: R32 Lines of business HTML 177K
50: R33 International Operations HTML 114K
51: R34 Supplemental information to the Consolidated HTML 68K
Statement of Cash Flows
52: R35 Summary of significant accounting and reporting HTML 244K
policies (Policies)
53: R36 Summary of significant accounting and reporting HTML 59K
policies Summary of significant accounting and
reporting policies (Tables)
54: R37 Securities (Tables) HTML 621K
55: R38 Loans and asset quality (Tables) HTML 516K
56: R39 Goodwill and intangible assets (Tables) HTML 172K
57: R40 Other assets (Tables) HTML 94K
58: R41 Net interest revenue (Tables) HTML 90K
59: R42 Noninterest Expense (Tables) HTML 82K
60: R43 Income Taxes (Tables) HTML 142K
61: R44 Long-Term Debt (Tables) HTML 109K
62: R45 Securitizations and variable interest entities HTML 115K
(Tables)
63: R46 Shareholders' equity (Tables) HTML 160K
64: R47 Other comprehensive income (Loss) (Tables) HTML 185K
65: R48 Stock-based compensation (Tables) HTML 106K
66: R49 Employee benefit plans (Tables) HTML 573K
67: R50 Company Financial Information (Tables) HTML 165K
68: R51 Fair value measurement (Tables) HTML 771K
69: R52 Fair value option (Tables) HTML 82K
70: R53 Commitments and contingent liabilities (Tables) HTML 97K
71: R54 Derivative instruments (Tables) HTML 462K
72: R55 Lines of business (Tables) HTML 152K
73: R56 International Operations (Tables) HTML 113K
74: R57 Supplemental information to the Consolidated HTML 66K
Statement of Cash Flows (Tables)
75: R58 Summary of significant accounting and reporting HTML 84K
policies (Details)
76: R59 Summary of significant accounting and reporting HTML 59K
policies - Equity Method Investments (Details)
77: R60 Acquisitions and dispositions (Details) HTML 105K
78: R61 Securities - Amortized Cost, Gross Unrealized HTML 152K
Gains and Losses and Fair Value of Securities
(Detail)
79: R62 Securities - Securities Transferred From AFS to HTML 51K
HTM (Details)
80: R63 Securities - Net Securities Gains (Losses) HTML 56K
(Detail)
81: R64 Securities - Aggregate Fair Value of Investments HTML 171K
with Continuous Unrealized Loss Position (Detail)
82: R65 Securities - Maturity Distribution by Carrying HTML 161K
Amount and Yield (on Tax Equivalent Basis) of
Investment Securities Portfolio (Detail)
83: R66 Securities - Projected Weighted-Average Default HTML 59K
Rates and Loss Severities (Detail)
84: R67 Securities - Pre-Tax Net Securities Gains (Losses) HTML 62K
by Type (Detail)
85: R68 Securities - Debt Securities Credit Losses Roll HTML 59K
Forward Recorded in Earnings (Detail)
86: R69 Securities - Pledged assets (Details) HTML 73K
87: R70 Loans and asset quality - Details of Loan HTML 96K
Distribution and Industry Concentrations of Credit
Risk (Detail)
88: R71 Loans and asset quality - Allowance for Credit HTML 168K
Losses Activity (Details)
89: R72 Loans and asset quality - Nonperforming Assets HTML 66K
(Detail)
90: R73 Loans and asset quality - Lost Interest (Detail) HTML 55K
91: R74 Loans and asset quality - Information about HTML 111K
Impaired Loans (Detail)
92: R75 Loans and asset quality - Information about Past HTML 82K
Due Loans (Detail)
93: R76 Loans and asset quality- Troubled Debt HTML 62K
Restructurings (Detail)
94: R77 Loans and asset quality - Credit Quality HTML 75K
Indicators - Wealth Management Loans and Mortgages
- Credit Risk Profile by Internally Assigned Grade
(Detail)
95: R78 Loans and asset quality - Additional Information HTML 115K
(Details)
96: R79 Goodwill and intangible assets - Goodwill by HTML 73K
Business Segment (Detail)
97: R80 Goodwill and intangible assets - Intangible Assets HTML 71K
by Business Segment (Detail)
98: R81 Goodwill and intangible assets - Intangible Assets HTML 83K
by Type (Detail)
99: R82 Goodwill and intangible assets - Estimated Annual HTML 59K
Amortization Expense (Detail)
100: R83 Other assets (Detail) HTML 87K
101: R84 Other assets - Seed Capital and Private Equity HTML 67K
Investments Valued Using Net Asset Value (Detail)
102: R85 Other assets - Qualified Affordable Housing HTML 69K
Project Investments (Details)
103: R86 Deposits - Additional Information (Detail) HTML 65K
104: R87 Net interest revenue (Details) HTML 103K
105: R88 Noninterest Expense (Detail) HTML 85K
106: R89 Income Taxes - Narrative (Detail) HTML 74K
107: R90 Income Taxes - Provision (Benefit) for Income HTML 79K
Taxes from Continuing Operations (Detail)
108: R91 Income Taxes - Components of Income (Loss) before HTML 54K
Taxes (Detail)
109: R92 Income Taxes - Components of Net Deferred Tax HTML 80K
Liability (Detail)
110: R93 Income Taxes - Reconciliation of Statutory Federal HTML 77K
Income Tax Rate to Effective Income Tax Rate
(Detail)
111: R94 Income Taxes - Unrecognized Tax Positions (Detail) HTML 64K
112: R95 Long-Term Debt - Schedule of Long-term Debt HTML 70K
(Detail)
113: R96 Long-Term Debt - Summary of Trust Preferred HTML 67K
Securities Issued by Trusts (Detail)
114: R97 Long-Term Debt - Additional Information (Detail) HTML 68K
115: R98 Securitizations and variable interest entities - HTML 85K
Incremental Assets and Liabilities of Variable
Interest Entities Included in Consolidated
Financial Statements (Detail)
116: R99 Securitizations and variable interest entities - HTML 59K
Non-consolidated Variable Interest Entities
(Detail)
117: R100 Shareholders' equity - Narrative (Details) HTML 112K
118: R101 Shareholders' equity - Summary (Details) HTML 92K
119: R102 Shareholders' equity - Capital adequacy (Details) HTML 150K
120: R103 Other comprehensive income (loss) - Components HTML 117K
(Details)
121: R104 Other comprehensive income (loss) Other HTML 78K
Comprehensive Income (Loss) - Changes in
Accumulated Other Comprehensive Income (Loss)
(Details)
122: R105 Stock-based compensation - Additional Information HTML 109K
(Detail)
123: R106 Stock-based compensation - Summary of Stock Option HTML 91K
Activity (Detail)
124: R107 Stock-based compensation - Stock Options HTML 83K
Outstanding (Detail)
125: R108 Stock-based compensation - Aggregate Intrinsic HTML 53K
Value of Options (Detail)
126: R109 Stock-based compensation - Nonvested Restricted HTML 73K
Stock and Restricted Stock Units Activity (Detail)
127: R110 Employee Benefit Plans - Combined Data for HTML 157K
Domestic and Foreign Defined Benefit Pension and
Post Retirement Healthcare Plans (Detail)
128: R111 Employee Benefit Plans - Net Periodic Benefit HTML 111K
(Credit) Cost (Details)
129: R112 Employee Benefit Plans - Changes in Other HTML 76K
Comprehensive Income (Loss) (Details)
130: R113 Employee Benefit Plans - Amounts Expected to be HTML 61K
Recognized in Net Periodic Benefit Income (Cost)
(Details)
131: R114 Employee Benefit Plans - Defined Benefit Plan HTML 64K
Funded Status of Plan (Details)
132: R115 Employee Benefit Plans - Plans with Obligations in HTML 61K
Excess of Plan Assets (Details)
133: R116 Employee Benefit Plans - Benefit Payments for BNY HTML 77K
Mellons Pension and Healthcare Plans Expected to
be Paid (Details)
134: R117 Employee Benefit Plans - Pension Investment Asset HTML 75K
Allocation (Detail)
135: R118 Employee Benefit Plans - Pension Plan Investment HTML 171K
Assets Measured at Fair Value on Recurring Basis
(Detail)
136: R119 Employee Benefit Plans - Rollforward of Plan HTML 67K
Investment Assets Including Change in Fair Value
Classified in Level 3 of Valuation Hierarchy
(Detail)
137: R120 Employee Benefit Plans - Pension Plan Assets HTML 78K
Valued Using Net Asset Value (Detail)
138: R121 Employee Benefit Plans - Additional Information HTML 127K
(Detail)
139: R122 Company Financial Information Condensed Income HTML 92K
Statement Parent Corporation (Details)
140: R123 Company Financial Information Condensed Balance HTML 95K
Sheet Parent Corporation (Details)
141: R124 Company Financial Information Condensed Statement HTML 131K
of Cash Flows Parent Corporation (Details)
142: R125 Company Financial Information - Additional HTML 87K
Information (Details)
143: R126 Fair value measurement - Assets and Liabilities HTML 285K
Measured at Fair Value on Recurring Basis
(Details)
144: R127 Fair value measurement - Details of Certain Items HTML 213K
Measured at Fair Value on Recurring Basis
(Details)
145: R128 Fair value measurement - Significant Unobservable HTML 107K
Inputs (Details)
146: R129 Fair value measurement - Assets Measured at Fair HTML 67K
Value on Nonrecurring Basis (Details)
147: R130 Fair value measurement - Carrying Amount and Fair HTML 100K
Value of Financial Instruments (Details)
148: R131 Fair value measurement - Summary of Carrying HTML 59K
Amount of Hedged Financial Instruments, Related
Notional Amount of Hedge and Estimated Fair Value
of Derivatives (Details)
149: R132 Fair Value Measurement - Additional Information HTML 52K
(Details)
150: R133 Fair value option - Assets and Liabilities, by HTML 64K
Type, of Consolidated Investment Management Funds
Recorded at Fair Value (Detail)
151: R134 Fair value option - Changes in Fair Value of the HTML 56K
Loans and Long-Term Debt and the Location of the
Changes (Details)
152: R135 Fair value option - Narrative (Details) HTML 57K
153: R136 Commitments and contingent liabilities - HTML 88K
Significant Industry Concentrations Related to
Credit Exposure (Details)
154: R137 Commitments and contingent liabilities - Summary HTML 62K
of Off-Balance Sheet Credit Risks, Net of
Participations (Details)
155: R138 Commitments and contingent liabilities - Standby HTML 56K
Letters of Credits by Investment Grade (Details)
156: R139 Commitments and contingent liabilities - Narrative HTML 124K
(Details)
157: R140 Derivative instruments - Narrative (Details) HTML 95K
158: R141 Derivative instruments - Ineffectiveness Related HTML 60K
to Derivatives and Hedging Relationships Recorded
in Income (Details)
159: R142 Derivative instruments - Impact of Derivative HTML 99K
Instruments on Balance Sheet (Details)
160: R143 Derivative instruments - Impact of Derivative HTML 92K
Instruments on Income Statement (Details)
161: R144 Derivative instruments - Revenue from Foreign HTML 57K
Exchange and Other Trading (Details)
162: R145 Derivative instruments - Fair Value of Derivative HTML 59K
Contracts Falling under Early Termination
Provisions in Net Liability Position (Details)
163: R146 Derivative instruments - Offsetting (Details) HTML 239K
164: R147 Derivative instruments - Secured Borrowings HTML 106K
(Details)
165: R148 Lines of business - Narrative (Details) HTML 56K
166: R149 Lines of business - Contribution of Segments to HTML 97K
Overall Profitability (Details)
167: R150 International Operations - Foreign Revenue, Income HTML 73K
before Income Taxes, Net Income and Assets from
Foreign Operations (Detail)
168: R151 International Operations (Details) HTML 58K
169: R152 Supplemental information to the Consolidated HTML 68K
Statement of Cash Flows- Noncash Investing and
Financing Transactions that are Not Reflected in
Consolidated Statement of Cash Flows (Detail)
171: XML IDEA XML File -- Filing Summary XML 326K
170: EXCEL IDEA Workbook of Financial Reports XLSX 284K
12: EX-101.INS XBRL Instance -- bk-20161231 XML 16.76M
14: EX-101.CAL XBRL Calculations -- bk-20161231_cal XML 709K
15: EX-101.DEF XBRL Definitions -- bk-20161231_def XML 2.37M
16: EX-101.LAB XBRL Labels -- bk-20161231_lab XML 4.91M
17: EX-101.PRE XBRL Presentations -- bk-20161231_pre XML 3.19M
13: EX-101.SCH XBRL Schema -- bk-20161231 XSD 523K
172: ZIP XBRL Zipped Folder -- 0001390777-17-000065-xbrl Zip 972K
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/28/17 | 4 | ||
| For Period end: | 12/31/16 | 11-K, 13F-HR, 5, 8-K | ||
| 12/31/15 | 10-K, 11-K, 13F-HR, 5, 8-K | |||
| 12/31/14 | 10-K, 11-K, 13F-HR, 13F-HR/A, 5, 8-K, ARS | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/08/21 Bank of New York Mellon Corp. 424B2 1:761K Donnelley … Solutions/FA |